1.Documented symptomatic(fever of 100.5°F or more or 38°C shortness of breath cough anosmia GI disturbances persisting myalgiaetc any one of them present).) COVID19 positive patients. <br/ >2.Male 18-60 years of age <br/ >3.Female 40-60 years of age with one year amenorrhoea. <br/ >4.Ready to participate and provide informed consent. <br/ >5.Patients enrolled shall not be the part of any other drug trial. <br/ > <br/ >

1.Documented symptomatic(fever of 100.5°F or more or 38°C shortness of breath cough anosmia GI disturbances persisting myalgiaetc any one of them present).) COVID19 positive patients. <br/ >2.Male 18-60 years of age <br/ >3.Female 40-60 years of age with one year amenorrhoea. <br/ >4.Ready to participate and provide informed consent. <br/ >5.Patients enrolled shall not be the part of any other drug trial. <br/ > <br/ >

1.Documented symptomatic(fever of 100.5°F or more or 38°C shortness of breath cough anosmia GI disturbances persisting myalgiaetc any one of them present).) COVID19 positive patients. <br/ >2.Male 18-60 years of age <br/ >3.Female 40-60 years of age with one year amenorrhoea. <br/ >4.Ready to participate and provide informed consent. <br/ >5.Patients enrolled shall not be the part of any other drug trial. <br/ > <br/ >

1.Documented symptomatic(fever of 100.5°F or more or 38°C shortness of breath cough anosmia GI disturbances persisting myalgiaetc any one of them present).) COVID19 positive patients. <br/ >2.Male 18-60 years of age <br/ >3.Female 40-60 years of age with one year amenorrhoea. <br/ >4.Ready to participate and provide informed consent. <br/ >5.Patients enrolled shall not be the part of any other drug trial. <br/ > <br/ >